Oxycodone
- Generic Name
- Oxycodone
- Brand Names
- Endocet, Endodan Reformulated May 2009, Nalocet, Oxaydo, Oxy.IR, Oxycontin, Oxyneo, Percocet, Prolate, Rivacocet, Roxicet, Roxicodone, Roxybond, Targin, Targiniq, Xolox, Xtampza
- Drug Type
- Small Molecule
- Chemical Formula
- C18H21NO4
- CAS Number
- 76-42-6
- Unique Ingredient Identifier
- CD35PMG570
- Background
Oxycodone is a semisynthetic opioid analgesic derived from thebaine in Germany in 1917. It is currently indicated as an immediate release product for moderate to severe pain and as an extended release product for chronic moderate to severe pain requiring continuous opioid analgesics for an extended period. The first oxycodone containing product, Percodan, wa...
- Indication
Oxycodone is indicated for the treatment of moderate to severe pain. There is also an extended release formulation indicated for chronic moderate to severe pain requiring continuous opioid analgesics for an extended period.
- Associated Conditions
- Severe Acute Pain, Severe Pain, Severe, Chronic Pain, Acute, moderate Pain, Chronic, moderate Pain
- Associated Therapies
- -
Opioid-Free Pain Control Regimen Following Robotic Radical Prostatectomy
- Conditions
- Interventions
- First Posted Date
- 2022-10-28
- Last Posted Date
- 2024-04-18
- Lead Sponsor
- Wake Forest University Health Sciences
- Target Recruit Count
- 100
- Registration Number
- NCT05597878
- Locations
- 🇺🇸
Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, North Carolina, United States
A Study to Evaluate the Intranasal Abuse Potential of PF614 in Non-Dependent Recreational Opioid Users
- Conditions
- Interventions
- First Posted Date
- 2022-10-05
- Last Posted Date
- 2022-12-27
- Lead Sponsor
- Ensysce Biosciences
- Target Recruit Count
- 27
- Registration Number
- NCT05567354
- Locations
- 🇺🇸
Ohio Clinical Trails, Columbus, Ohio, United States
Use of Oxycodone in Bariatric Surgery
- Conditions
- Interventions
- First Posted Date
- 2022-08-25
- Last Posted Date
- 2022-08-25
- Lead Sponsor
- Qiang Fu
- Target Recruit Count
- 90
- Registration Number
- NCT05515822
Non-intrusive Detection of Temporary Neurologic Impairment by Opioids
- First Posted Date
- 2022-08-05
- Last Posted Date
- 2022-08-05
- Lead Sponsor
- Zxerex Corporation
- Target Recruit Count
- 17
- Registration Number
- NCT05489601
- Locations
- 🇺🇸
Mayo Clinic, Scottsdale, Arizona, United States
Clinical Application Value of Remazolam Combined With Sugammadex Sodium in Anesthesia for Endotracheal Surgery Under Bronchoscopy
- First Posted Date
- 2022-07-21
- Last Posted Date
- 2022-10-26
- Lead Sponsor
- Zhejiang Cancer Hospital
- Target Recruit Count
- 34
- Registration Number
- NCT05468671
- Locations
- 🇨🇳
Zhejiang Cancer Hospital, Hanzhou, China
Compare Continuous Gastrocnemius Plane Block With Intravenous Analgesia After Foot and Ankle Surgery
- Conditions
- Interventions
- First Posted Date
- 2022-07-19
- Last Posted Date
- 2022-07-19
- Target Recruit Count
- 60
- Registration Number
- NCT05463809
Safety, Tolerability and Pharmacokinetics of NYX-783 and Oxycodone DDI Study
- Conditions
- Interventions
- First Posted Date
- 2022-07-07
- Last Posted Date
- 2024-08-28
- Lead Sponsor
- Yale University
- Target Recruit Count
- 9
- Registration Number
- NCT05447286
- Locations
- 🇺🇸
Cmhc/Cnru, New Haven, Connecticut, United States
🇺🇸The Yale Stress Center: Yale University, New Haven, Connecticut, United States
Opioid Reduction Toolkit Reduces Opioids Prescribed and Consumed
- First Posted Date
- 2022-05-05
- Last Posted Date
- 2024-04-22
- Lead Sponsor
- Thomas Jefferson University
- Target Recruit Count
- 159
- Registration Number
- NCT05363436
- Locations
- 🇺🇸
Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States
Toward Zero Prescribed Opioids for Outpatient General Surgery
- Conditions
- Interventions
- First Posted Date
- 2022-04-14
- Last Posted Date
- 2023-06-05
- Lead Sponsor
- Thomas Jefferson University
- Target Recruit Count
- 129
- Registration Number
- NCT05327777
- Locations
- 🇺🇸
Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States
Precision Opioid Care After Cesarean Delivery (PRECISE-CD)
- First Posted Date
- 2022-03-15
- Last Posted Date
- 2024-07-05
- Lead Sponsor
- Grace Lim, MD, MS
- Target Recruit Count
- 341
- Registration Number
- NCT05280743
- Locations
- 🇺🇸
Magee Women's Hospital of UPMC, Pittsburgh, Pennsylvania, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.